Effect of Acute Hypoxia on RIght VEntRicular Function in Asthma.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Normobaric Hypoxia.
- Who it may be relevant to
- Registry conditions: Hypoxia, Altitude, Hypoxia, Normobaric Hypoxia, Right Ventricular Function. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Acute Hypoxia on RIght VEntRicular Function. A Single-Center, Double-Blind, Randomized Controlled Cross-Over Trial.
Overview
More and more people are engaging in sports in the mountains, including individuals with heart or lung diseases. At the same time, such diseases are becoming more common in Switzerland. At high altitude, less oxygen is available, which places stress on the body-particularly on the heart, which has to pump blood through the lungs. How the heart, especially the right ventricle, in people with asthma responds to this stress is still not well understood. Therefore, this study investigates how the heart responds to simulated altitudes of 2,500 m and 4,000 m, both at rest and during light physical activity in patients with asthma. The primary objective is to assess how right ventricular function changes under conditions of reduced oxygen availability. In addition, vital signs, changes in blood gases, oxygen levels in blood and tissue and shortness of breath are assessed. The "altitude" is simulated using a special gas mixture that participants inhale. Participants undergo three altitude conditions (490, 2,500, and 4,000 m above sea level). The order of the altitude conditions is assigned at random. The aim is to better understand how the right ventricle and other parameters respond to low-oxygen conditions and how affected patients can be better supported in the future.
Detailed description
Outdoor activities in the mountains are becoming increasingly popular. At higher altitudes, the air contains less oxygen, which puts extra strain on the body-especially on the heart. The right side of the heart plays a key role in pumping blood through the lungs and may need to work harder when oxygen levels are low. While the heart's response to long-term altitude exposure is relatively well known, much less is understood about how the heart reacts to short-term (acute) exposure to low oxygen, particularly during light physical activity and in individuals with asthma.
This study aims to better understand how the right ventricle responds to short-term simulated altitude exposure. Participants with asthma will be exposed to different oxygen levels that correspond to altitudes of 490 m (near sea level), 2,500 m, and 4,000 m, both at rest and during light cycling exercise.
The main focus of the study is to measure changes in right ventricular function, assessed using a non-invasive heart ultrasound technique called speckle-tracking echocardiography. In addition, heart rate, blood pressure, oxygen saturation, and symptoms such as shortness of breath and leg fatigue will be recorded.
The study is conducted at a single center and uses a randomized, double-blind, cross-over design, meaning that each participant undergoes all altitude conditions in a random order, and neither the participants nor the investigators know which altitude is being simulated at a given time.
Participants Only adults aged 18-80 years with diagnosed asthma bronchiale will be included. Participants must live below 800 m above sea level and must not have been exposed to higher altitudes for more than 24 hours in the three weeks before participation. Individuals with significant other medical conditions, pregnancy, need for long-term oxygen therapy, or inability to follow the study procedures will be excluded.
Study procedures
Each study visit includes:
* 1 hour resting period * Measurement of vital signs (heart rate, blood pressure, oxygen saturation) * Heart ultrasound at rest * A 10-minute low-intensity cycling exercise * Repeated heart ultrasound during and symptom assessment after exercise * Low-oxygen conditions are created using a special gas mixture that participants breathe through a mask. Each condition is separated by at least 2 hours wash-out period to ensure recovery.
Study size and duration Based on statistical calculations, 18 participants will be recruited to allow balanced allocation across all study conditions and to account for potential dropouts. Participation may take place over two to three days, depending on the preferred schedule of the participant. The days can be spread or be spread over several weeks, depending on individual availability.
Aim of the study The goal of this study is to improve understanding of how the right side of the heart responds to short-term low-oxygen exposure at rest and during light exercise. This knowledge will help interpret future findings in patients with heart or lung disease and may contribute to safer recommendations for physical activity at altitude.
Interventions
- Other Normobaric Hypoxia
Normobaric hypoxia according to 408m (control/normobaric normoxia), 2500 m and 4000 m above sea-level at rest for 1 hour and at low intensity cycling for 10 minutes (5 min 30 W, 5 min 60 W).
Primary outcome measures
- Right ventricular free wall strain [Time frame: It will be assessed once at baseline in rest and during each condition three times: Once after 1 hour in the specific condition at rest, then during the 5 min of 30 Watt cycling and during the 5 min of 60 Watt cycling.]
Secondary outcome measures (12)
- Tricuspid annular plane systolic excursion (TAPSE) [Time frame: It will be assessed once at baseline in rest and during each condition three times: Once after 1 hour in the specific condition at rest, then during the 5 min of 30 Watt cycling and during the 5 min of 60 Watt cycling.]
- Right ventricular-arterial coupling [Time frame: It will be assessed once at baseline in rest and during each condition three times: Once after 1 hour in the specific condition at rest, then during the 5 min of 30 Watt cycling and during the 5 min of 60 Watt cycling.]
- RV/PA [Time frame: It will be assessed once at baseline in rest and during each condition three times: Once after 1 hour in the specific condition at rest, then during the 5 min of 30 Watt cycling and during the 5 min of 60 Watt cycling.]
- Stroke volume [Time frame: It will be assessed once at baseline in rest and during each condition three times: Once after 1 hour in the specific condition at rest, then during the 5 min of 30 Watt cycling and during the 5 min of 60 Watt cycling.]
- Heart rate [Time frame: It will be assessed at baseline and continuously measured during each condition (1 hour resting period and during the 10 minutes cycling).]
- Blood pressure [Time frame: It will be measured at baseline once and during each condition six times: Four times during the resting period (every 15 min) and two times during low load cycling.]
- Borg Rating of Perceived Exertion Scale (CR10) [Time frame: Measured at baseline and in each condition twice: Once at the end of the resting condition and again at the end of the cycling exercise.]
- Oxygen saturation [Time frame: It will be assessed at baseline and continuously measured during each condition (1 hour resting period and during the 10 minutes cycling).]
- Lung tissue oxygenation [Time frame: It will be assessed at baseline and continuously measured during each condition (1 hour resting period and during the 10 minutes cycling).]
- Brain oxygenation [Time frame: It will be assessed at baseline and continuously measured during the 1 hour resting period during each condition, and during the 10 minutes cycling.]
- Respiratory effort [Time frame: It will be assessed at baseline and continuously measured during each condition (1 hour resting period and during the 10 minutes cycling).]
- Multiomics profiles [Time frame: A blood sample will be collected during each condition after 1 hour of rest.]
Eligibility criteria
Inclusion criteria
- Signed informed consent
- Diagnosed and well controlled asthma bronchiale
- 18-80 years (age group young: 18-39.99 years / age group older: 40-80 years)
- All sex and genders
- Living <800m and without altitude exposure > 2500 m and > 24h within the last three weeks
Exclusion criteria
- <18, >80 years old
- Any other diagnosed cardiopulmonary condition including past HAPE
- Other clinically significant severe concomitant disease states (e.g. renal, hepatic dysfunction, etc.)
- Inability to follow the procedures of the study due to language problems, psychological neurological disorders or orthopaedic disorders
- Participants permanently living >800m and altitude exposure > 2500 m and >24h within the last three weeks
- Pregnancy: Participants will be asked if pregnant or not, no screening for undetected pregnancy
- Lactating women
- Participation in other study with active treatment
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple blind
- Primary purpose
- Diagnostic
Study locations
Switzerland · 1 center
- Consultant Clinic of Pulmonology, University Hospital of Zurich — Zurich
Identifiers
NCT: NCT07431580 · RIVER-Asthma